The EVAR Center

Filter Your Results

 

News

 

FDA Clears Stroke2prevent's A-View Balloon Catheter for TEE

May 30, 2017 -- Stroke2prevent, a medical device company based in Zwolle, The Netherlands, announced that it has received US Food and Drug Administration 510(k) clearance for …

Endologix Reports 30-Day Data From the Ovation LUCY Study

May 31, 2017 -- Endologix, Inc. announced 30-day results from the LUCY study, which is an evaluation of endovascular aneurysm repair (EVAR) using the company's ultra-low-p…

Gore's Excluder Iliac Branch Endoprosthesis Approved in Japan

May 24, 2017 -- Gore & Associates announced the first implantation procedures in Japan of the company's Excluder iliac branch endoprosthesis (IBE), which received…

Results Published From the Pivotal Trial of Bolton Medical's Relay TEVAR Device

May 23, 2017 -- The initial and midterm results of the pivotal trial for the Relay thoracic stent graft (Bolton Medical) for thoracic endovascular aortic repair (TEVAR) of tho…

Endologix to Seek FDA Approval of Nellix EVAS System With Confirmatory Study

May 17, 2017 -- Endologix, Inc. announced it will seek US Food and Drug Administration (FDA) approval for its Nellix endovascular aneurysm sealing (EVAS) system by conducting …

Lombard Medical Begins ALTITUDE Enrollment in United Kingdom

May 15, 2017 -- Lombard Medical, Inc. announced that it has enrolled and treated the first patient in the company's ALTITUDE global registry to evaluate its Altura endogra…

An Interview With Christoph A. Nienaber, MD, PhD, FESC, FAHA

May 2017—Prof. Nienaber discusses current and emerging methods for aortic dissection care, as well as the recent work of the International Registry of Aortic Dissection (IRAD) organization.

Long-Term Data Show Durability of TEVAR in High-Risk Patients

May 9, 2017 -- Long-term data on the safety and durability of thoracic endovascular aortic repair (TEVAR) with the Zenith TX1 and TX2 devices (Cook Medical) were published by …

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.